Rifaximin versus Placebo Preventing the Recurrence of Clinically Overt Hepatic Encephalopathy in Patients having Cirrhosis of Liver. mfm [Internet]. 2024 May 19 [cited 2026 Jan. 31];28(12). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/4304